Advertisement
Skip to Content

Pacer BioThreat Strategy ETF VIRS

Quantitative rating as of

Morningstar’s Analysis VIRS

Will VIRS outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Summary

|

Pacer BioThreat Strategy ETF’s management team is just average, but a solid investment process still helps this strategy retain its Morningstar Quantitative Rating of Bronze. The strategy charges fees in line with its similarly distributed peers, priced within the middle quintile.

Unlock our full analysis with Morningstar Investor